Epitomee Medical is a pioneering brand that is revolutionizing the treatment and management of chronic diseases. They specialize in the development and commercialization of ingestible therapeutic devices that target the gastrointestinal tract. These innovative devices deploy targeted therapies, providing self-managed and safer treatment options for a range of prevalent chronic diseases.

Led by a team of experienced leaders, including CEO Dr. Dan Hashimshony, who has a strong background in science and engineering, Epitomee Medical is dedicated to improving patient care. Their devices have undergone rigorous testing, product development stages, and regulatory approval processes to ensure their safety and efficacy.

Epitomee Medical's products offer a kinder approach to treatment, with a focus on making the system more manageable for patients. By harnessing advanced technology and medical expertise, they are spearheading a transformation in healthcare. In addition to their innovative devices, Epitomee Medical also collaborates with various partners and stays up-to-date with the latest developments in the field.

They are committed to making a significant impact on the lives of individuals dealing with chronic diseases, offering a glimmer of hope for a better future